Finance

Lists
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
US$48,27
+2,38%
(+1,12) 1D
US$48,27
0,00% (0,00)
After hours
Closed: 14 ສ.ຫ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SUPN...
Open
US$46,70
High
US$48,39
Low
US$46,57
Mkt. cap
໒,໘໑ ຕື້
Avg. vol.
໙໘໖,໑໙ ພັນ
Volume
໓໓໑,໗໓ ພັນ
52-wk high
US$59,68
52-wk low
US$41,78
EPS
US$-1,91
Beta
໐,໕໖
Shares outstanding
໕໘,໑໓ ລ້ານ
No. of employees
໗໗໘
Open
US$46,70
High
US$48,39
Low
US$46,57
Mkt. cap
໒,໘໑ ຕື້
Avg. vol.
໙໘໖,໑໙ ພັນ
Volume
໓໓໑,໗໓ ພັນ
52-wk high
US$59,68
52-wk low
US$41,78
EPS
US$-1,91
Beta
໐,໕໖
Shares outstanding
໕໘,໑໓ ລ້ານ
No. of employees
໗໗໘
News stories
From web sources and news partners
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees778
Founded2005
HeadquartersRockville, ແມຣີແລນ, ສະຫະລັດ
SectorPharmaceutical industry
Websitesupernus.com
Analyst ratings
Based on 5 analysts giving stock ratings to SUPN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SUPN in the last 3 months.
Highest
Current US$48,27
US$67,00 (+38,80%)
Average
US$65,20 (+35,07%)
Lowest
US$63,00 (+30,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stacy Ku
TD Cowen
Buy
Maintained
US$65,00
+34,7%
08/03/2026
David Amsellem
Piper Sandler
Buy
Reiterated
US$66,00
+36,7%
07/27/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$63,00
+30,5%
07/13/2026
Chi Meng Fong
Bank of America Securities
Buy
Maintained
US$63,00
+30,5%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$65,00
+34,7%
07/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$67,00
+38,8%
07/09/2026
Annabel Samimy
Stifel Nicolaus
Hold
Maintained
US$55,00
+13,9%
05/06/2026
Pavan Patel
Bank of America Securities
Buy
Maintained
US$65,00
+34,7%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
192,10 ລ້ານ
211,57 ລ້ານ
207,70 ລ້ານ
219,06 ລ້ານ
Cost of goods sold
48,33 ລ້ານ
50,83 ລ້ານ
62,83 ລ້ານ
63,13 ລ້ານ
Cost of revenue
48,33 ລ້ານ
50,83 ລ້ານ
62,83 ລ້ານ
63,13 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110,97 ລ້ານ
124,44 ລ້ານ
126,67 ລ້ານ
136,04 ລ້ານ
Operating expense
135,30 ລ້ານ
148,96 ລ້ານ
152,32 ລ້ານ
161,37 ລ້ານ
Total operating expenses
183,63 ລ້ານ
199,80 ລ້ານ
215,15 ລ້ານ
224,50 ລ້ານ
Operating income
8,48 ລ້ານ
11,77 ລ້ານ
-7,44 ລ້ານ
-5,44 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-57,95 ລ້ານ
-1,91 ລ້ານ
-5,95 ລ້ານ
-57,65 ລ້ານ
EBT excluding unusual items
10,75 ລ້ານ
14,24 ລ້ານ
-5,06 ລ້ານ
-5,13 ລ້ານ
Income tax expense
-12,84 ລ້ານ
2,19 ລ້ານ
-3,66 ລ້ານ
723,00 ພັນ
Effective tax rate
22,15%
-114,47%
61,46%
-1,25%
Other operating expenses
-
-
-
-
Net income
-45,12 ລ້ານ
-4,10 ລ້ານ
-2,29 ລ້ານ
-58,37 ລ້ານ
Net profit margin
-23,49%
-1,94%
-1,10%
-26,65%
Earnings per share
0,61
0,88
0,21
0,53
Interest and investment income
2,28 ລ້ານ
2,46 ລ້ານ
2,38 ລ້ານ
2,63 ລ້ານ
Interest expense
-
-
-
-2,32 ລ້ານ
Net interest expenses
2,28 ລ້ານ
2,46 ລ້ານ
2,38 ລ້ານ
315,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
33,28 ລ້ານ
36,79 ລ້ານ
18,69 ລ້ານ
20,30 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google